Deriphylline Toxicity
Yes, deriphylline tablets can cause toxicity, particularly affecting the cardiovascular, central nervous system, and gastrointestinal systems, similar to other xanthine derivatives like theophylline.
Mechanism and Risk Factors
Deriphylline is a xanthine derivative similar to theophylline, which has well-documented toxicity profiles. As a methylxanthine, it can cause significant adverse effects when blood levels exceed the therapeutic range 1.
Risk factors that increase the likelihood of deriphylline toxicity include:
- High daily doses (>10 mg/kg/day in adults)
- Drug interactions (particularly with erythromycin and other medications that inhibit cytochrome P450 enzymes) 2
- Hepatic or renal insufficiency
- Advanced age
- Concurrent illness
Clinical Manifestations of Toxicity
Deriphylline toxicity can manifest with various symptoms affecting multiple organ systems:
Cardiovascular Effects
- Tachycardia
- Tachyarrhythmias (supraventricular tachycardia)
- Hypotension in severe cases
Central Nervous System Effects
- Headache
- Seizures (particularly in severe toxicity)
- Central nervous system stimulation
- Dizziness
- Insomnia
Gastrointestinal Effects
- Nausea
- Vomiting
- Gastric upset
- Aggravation of ulcer or reflux
Metabolic Effects
- Hyperglycemia
- Hypokalemia
- Metabolic acidosis in severe cases
Monitoring and Prevention
To prevent deriphylline toxicity:
- Start with appropriate dosing (10 mg/kg/day initially in adults, with maximum of 16 mg/kg/day) 1
- Monitor for early signs of toxicity (nausea, tachycardia, headache, insomnia)
- Avoid concomitant administration with drugs known to interact with xanthines
- Consider therapeutic drug monitoring in high-risk patients
- Adjust dosage in patients with hepatic or renal insufficiency
Management of Toxicity
If deriphylline toxicity is suspected:
- Discontinue the medication immediately
- Provide supportive care:
- Fluid and electrolyte management
- Antiemetics for nausea/vomiting
- Seizure control if needed
- In severe cases:
- Gastric lavage or emesis (if recent ingestion)
- Activated charcoal administration
- Multiple-dose activated charcoal may enhance elimination 3
- Charcoal hemoperfusion in life-threatening cases
Special Considerations
- Pediatric patients: Children may be more susceptible to toxicity and require careful dosing and monitoring 1
- Elderly patients: Lower doses are recommended due to decreased clearance
- Patients with hepatic impairment: At higher risk for toxicity due to reduced metabolism 4
- Drug interactions: Monitor closely when used with medications that inhibit cytochrome P450 enzymes 2
Conclusion
Deriphylline, like other xanthine derivatives, has a narrow therapeutic window and can cause significant toxicity. The risk increases with higher doses, drug interactions, and in patients with impaired drug clearance. Careful dosing, monitoring, and awareness of early toxicity signs are essential for safe use of this medication.